Integrative Proteomic Characterization of Human Lung AdenocarcinomaJun‐Yu Xu, Minjia Tan, Kun Qian et al.|Cell|2020Cited by 634
A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapiesZhiwei Liu, Minjia Tan, Yingluo Liu et al.|Molecular Cell|2021Cited by 55
Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesisPing Liu, Minjia Tan, Xiaoji Cong et al.|Cell Death and Differentiation|2021Cited by 43